Monday, November 30, 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV.

from Moneycontrol Business News https://ift.tt/33u15rC

No comments:

Post a Comment

Asian shares start cautiously, dollar edges down

Asian shares opened cautiously amid anticipation of fresh trade news influencing US asset demand. The dollar weakened as trade tensions and ...